Availability and Pricing of Orthobiologic Knee Injections Vary by Practice Type but Not by Community Socioeconomic Vulnerability in Suburban New York
Open Access
- 27 August 2026
- journal article
- research article
- Published by Wiley in Arthroscopy, Sports Medicine, and Rehabilitation
- Vol. 8 (5) , e70074
Abstract
Purpose: To assess the availability, price transparency, and pricing of platelet‐rich plasma (PRP), bone marrow aspirate concentration, and stem cell injections for knee osteoarthritis (OA) among orthopaedic sports medicine (OSM) practices and alternative clinics in suburban New York and to evaluate the impact of the economic status of a population on the availability and pricing of biologic injections. Methods: Between July and September 2025, OSM practices and alternative clinics offering PRP, bone marrow aspirate concentration, or stem cell injections for knee OA were identified through American Orthopaedic Society for Sports Medicine and Arthroscopy Association of North America databases and web searches. Clinics were contacted using a standardized telephone script. Analyses used Mann‐Whitney U, Fisher's exact, and Levene's tests. Associations with socioeconomic vulnerability were evaluated using the Social Vulnerability Index and Spearman correlation. Results: Seventy‐six (50 OSM, 26 alternative) of 91 clinics offered orthobiologics. PRP availability was similar between groups (98% vs 92%; P = .488), whereas stem cell injections were more common at alternative clinics (38% vs 6%; P < .001) and bone marrow aspirate concentration was rare (0% vs 4%; P = .329). PRP price disclosure was similar (84% vs 85%; P = .99). Median PRP price was $1000 for OSM and $875 for alternative clinics ( P = .059). Median stem cell price was $3500 at alternative clinics versus $750 at the single OSM listing ( P = .056). Clinic location vulnerability did not differ by provider type, and PRP price was not correlated with Social Vulnerability Index. Conclusions: Orthobiologic injections for knee OA are widely available in suburban New York. PRP is nearly universal, stem cell injections remain concentrated in alternative clinics, and pricing is unrelated to community socioeconomic vulnerability. Clinical Relevance: Orthobiologic injections for knee OA are broadly available in suburban practice settings, with variable pricing and transparency that have implications for patient counseling and shared decision‐making in an out‐of‐pocket market with limited clinical evidence.Keywords
This publication has 18 references indexed in Scilit:
- Orthobiologics in knee osteoarthritis, dream or reality?Archives of orthopaedic and trauma surgery, 2024
- Platelet‐Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra‐Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta‐analysisArthroscopy, 2024
- Physician and patient perceptions of surgical procedures for osteoarthritis of the knee in the United States, Europe, and Japan: results of a real-world studyBMC Musculoskeletal Disorders, 2022
- Regulatory and Ethical Aspects of Orthobiologic TherapiesOrthopaedic Journal of Sports Medicine, 2022
- The evolving regulatory landscape in regenerative medicineMolecular Aspects of Medicine, 2022
- How Does Platelet-Rich Plasma Compare Clinically to Other Therapies in the Treatment of Knee Osteoarthritis? A Systematic Review and Meta-analysisThe American Journal of Sports Medicine, 2022
- Stem Cells 101: ResponseThe American Journal of Sports Medicine, 2021
- American Medical Society for Sports Medicine Position Statement: Principles for the Responsible Use of Regenerative Medicine in Sports MedicineClinical Journal of Sport Medicine, 2021
- Nonoperative and Operative Soft‐Tissue and Cartilage Regeneration and Orthopaedic Biologics of the Knee: An Orthoregeneration Network (ON) Foundation ReviewArthroscopy, 2021
- The Cost Variability of OrthobiologicsSports Health: A Multidisciplinary Approach, 2019